Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2007-11-06
2007-11-06
Parkin, Jeffrey S. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S184100, C424S185100, C424S186100, C424S187100, C435S004000, C435S005000, C435S007100, C435S007900, C435S007920
Reexamination Certificate
active
11075480
ABSTRACT:
FIV gag polypeptides and a method and device for determining a feline immunodeficiency virus infection in an animal. The method includes contacting a biological sample from a felid with the FIV polypeptides and determining the binding of antibodies in the sample to the polypeptides. A device for detecting FIV antibodies is provided.
REFERENCES:
patent: 4629783 (1986-12-01), Cosand
patent: 4879212 (1989-11-01), Wang et al.
patent: 4900548 (1990-02-01), Kitchen
patent: 5037753 (1991-08-01), Pedersen et al.
patent: 5118602 (1992-06-01), Pedersen et al.
patent: 5177014 (1993-01-01), O'Connor et al.
patent: 5219725 (1993-06-01), O'Connor et al.
patent: 5565319 (1996-10-01), Pedersen et al.
patent: 5576177 (1996-11-01), Fridland et al.
patent: 5591572 (1997-01-01), Kemp et al.
patent: 5627026 (1997-05-01), O'Connor et al.
patent: 5648209 (1997-07-01), Avrameas et al.
patent: 5656732 (1997-08-01), Andersen et al.
patent: 5705331 (1998-01-01), Arthur et al.
patent: 5726013 (1998-03-01), Clark
patent: 5736378 (1998-04-01), Elder et al.
patent: 5750333 (1998-05-01), Clark
patent: 5820869 (1998-10-01), Wasmoen et al.
patent: 5833993 (1998-11-01), Wardley
patent: 5846825 (1998-12-01), Yamamoto
patent: 5849303 (1998-12-01), Wasmoen et al.
patent: 5994516 (1999-11-01), Pancino et al.
patent: 6077662 (2000-06-01), Compans et al.
patent: 6228608 (2001-05-01), Young et al.
patent: 6254872 (2001-07-01), Yamamoto
patent: 6284253 (2001-09-01), Barr et al.
patent: 6300118 (2001-10-01), Chavez et al.
patent: 6331616 (2001-12-01), Tompkins et al.
patent: 6383765 (2002-05-01), Andersen et al.
patent: 6391304 (2002-05-01), Richardson et al.
patent: 6447993 (2002-09-01), Yamamoto
patent: 6455265 (2002-09-01), Serres
patent: 6458528 (2002-10-01), Groat et al.
patent: 6503713 (2003-01-01), Rana
patent: 6613530 (2003-09-01), Wienhues et al.
patent: 0 602 406 (1997-11-01), None
patent: 0 962 774 (1999-12-01), None
patent: WO90/06510 (1990-06-01), None
patent: WO/90/13573 (1990-11-01), None
patent: WO92/09632 (1992-06-01), None
patent: WO92/22573 (1992-12-01), None
patent: WO93/01304 (1993-01-01), None
patent: WO94/02612 (1994-02-01), None
patent: WO94/06471 (1994-03-01), None
patent: WO96/40268 (1996-12-01), None
patent: WO96/40953 (1996-12-01), None
patent: WO96/40956 (1996-12-01), None
patent: WO96/40957 (1996-12-01), None
patent: WO97/07817 (1997-03-01), None
patent: WO99/29182 (1999-06-01), None
patent: WO 01/04280 (2001-01-01), None
patent: WO 03/015814 (2003-02-01), None
patent: WO 2004/100985 (2004-11-01), None
Wimley, William, et al.,Designing Transmembrane α-Helices that insert Spontaneously, Biochemistry, 39:4432-4442 (2000).
Ponsati, Berta, et al.,A Synthetic Strategy for Simulatenous Purification-Conjugation of Antigenic Peptides,Analytical Biochemistry, 181:389-395 (1989).
Rimmelzwaan, G.F., et al.,gag-And env-specific serum antibodies in cats after natural and experimental infection with feline immunodeficincy virus, Veterinary Microbiology, 39:153-165 (1994).
Calzolari, Marialaura, et al.,Serological diagnosis of feline immunodeficiency virus infection using recombinant transmembrane glycoprotein, Veterinary Immunology and Immunopathology, 46:83-92 (1995).
U.S. Appl. No. 10/938,097, filed Sep. 10, 2004, Groat et al.
U.S. Appl. No. 10/938,056, filed Sep. 10, 2004, Groat et al.
U.S. Appl. No. 11/015,675, filed Dec. 17, 2004, Groat et al.
U.S. Appl. No. 11/059,285, filed Feb. 16, 2005, Groat et al.
U.S. Appl. No. 11/076,820, filed Mar. 10, 2005, Groat et al.
U.S. Appl. No. 11/077,321, filed Mar. 10, 2005, Groat et al.
U.S. Appl. No. 11/075,958, filed Mar. 9, 2005, Groat et al.
Olmsted, R.A. et al, “Molecular cloning of the feline immunodeficiency virus”,Proc. Natl. Acad. Sci. USA, 1989, vol. 86, pp. 2448-2452.
Maki, N. et al., “Molecular Characterization and Heterogeneity of Feline Immunodeficiency Virus Isolates”,Archives of Virolology, 1992, vol. 123, pp. 29-45.
Yamamoto, J.K. et al., “Experimental Vaccine Protection against Homologous and Heterologous Strains of Feline Immunodeficiency Virus”,Journal of Virology, 1993, vol. 67, No. 1, pp. 601-605.
Hohdatsu, T. et al., “Effect of Dual-subtype Vaccine Against Feline Immunodeficiency Virus Infection”,Veterinary Microbiology, 1997, vol. 58, pp. 155-165.
Uhl, E.W. et al., “FIV Vaccine Development and its Importance to Veterinary and Human Medicine: A Review FIV Vaccine 2002 Update and Review”,Veterinary Immunology and Immunopathology, 2002, vol. 90, pp. 133-132.
Murray, D.M., “Identifying FIV Vaccinates”,Journal of the American Veterinary Medical Association, 2003, vol. 222, p. 710.
Moon, D., “Another Solution to Identify FIV-Vaccinated Cats”,Journal of the American Veterinary Medical Association, 2003, vol. 22, No. 9, p. 1207.
Calandrella, M., “Desitometric Analysis of Western Blot Assays for Feline Immunodeficiency Virus Antibodies”,Veterinary Immunology and Immunopathology, 2001, vol. 79, pp. 261-271.
Hartmann, K. et al., “Comparison of Six In-House Tests for the Rapid Diagnosis of Feline Immunodeficiency and Feline Leukemia Virus Infections”,The Veterinary Record, 2001, vol. 149, pp. 317-320.
Richardson, J., et al., “Delayed Infection after Immunization with a peptide from the Transmembrane Glycoprotein of the Feline Immunodeficiency Virus”,Journal of Virology, 1998, vol. 72, pp. 2406-2415.
Finerty, Susan, et al., “Mucosal immunization with experimental feline immunodeficiency virus (FIV) vaccines induces both antibody and T cell responses but does not protect against rectal FIV challenge”,Vaccine, 2000, vol. 18, pp. 3254-3265.
DeRonde, Anthony, et al., “Antibody Response in Cats to the Envelope Proteins of Feline Immunodeficincy Virus: identification of an Immunodominant Neutralization Domain”,Virology, 1994, vol. 198, pp. 257-264.
Lombardi, Stefania, et al., “Identification of a Linear Neutralization Site within the Third Variable region of the Feline Immunodeficiency Virus Envelope”,Journal of Virology, 1993, vol. 67, pp. 4742-4749.
Avrameas, A., et al., “Localisation of Three Epitopes of the ENV Protein of Feline Immunodeficiency Virus”,Molecular Immunology, 1992, vol. 29, pp. 565-572.
Avrameas, A., et al., “Serological Diagnosis of Feline Immunodeficiency Virus Infection Based on Synthetic Peptides from Env Glycoproteins”,Res. Virol, 1993, vol. 144, pp. 209-218.
Olmsted, Robert , “Nucleotide Sequence Analysis of Feline Immunodeficiency Virus: Genome Organization and Relationship to Other Lentiviruses”,Proc. Natl. Acad. Sci. USA, 1989, vol. 86, pp. 8088-8092.
Gallaher, William, et al., “A General Model for the Transmembrane Proteins of HIV and Other Retroviruses”,AIDS Research and Human Retroviruses, 1989, vol. 5, pp. 431-440.
Mermer, B., et al., “Similarities Between the Transmembrane Proteins of FIV and HIV”,Abstract distributed on and Poster Presentation during the Cold Spring Harbor Conference, 1991.
Javaherian, et al., “Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein”,Proc. Natl. Acad. Sci. USA, 1989, vol. 86, pp. 6768-6772.
Steinman, et al., “Biochemical and Immunological Characterization of the Major Structural Proteins of Feline Immunodeficiency Virus”,Journal of General Virology, 1990, vol. 71, pp. 701-706.
Gnann, et al, “Fine Mapping of an Immunodominant Domain in the Transmembrane Glycoprotein of Human Immunodeficiency Virus”,Journal of Virology, 1987, vol. 61, pp. 2639-2641.
Chong, et al., “Analysis of Equine Humoral Immune Responses to the Transmembrane Envelope Glycoprotein (gp45) of Equine Infectious Anemia Virus”,Journal of Virology, 1991, pp. 1013-1018.
Berton, et al., “The Antigenic Structure of the Influenza B Virus Hemagglutinin: Operational and Topological Mapping with Monoclonal Antibodies”, Virology, 1985, vol. 143, pp. 583-594.
Mermer, et al., “
Humphrey Louise
IDEXX Laboratories, Inc.
McDonnell Boehnen & Hulbert & Berghoff LLP
Parkin Jeffrey S.
LandOfFree
Method and device for detecting feline immunodeficiency virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and device for detecting feline immunodeficiency virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and device for detecting feline immunodeficiency virus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3822855